Background and Clinical Significance: Dystrophic calcinosis cutis involves calcium deposition in damaged or chronically inflamed tissues despite normal calcium and phosphate metabolism. Although typically associated with systemic sclerosis and dermatomyositis, it is rare in rheumatoid arthritis. Ulceration over calcified deposits may impair healing and function. This case highlights a staged reconstructive strategy to remove calcified tissue and achieve definitive wound closure. Case Presentation: A 73-year-old woman with a 22-year history of rheumatoid arthritis presented with painful, partially confluent pretibial ulcerations, purulent drainage, impaired mobility, and extrusion of chalk-like material. Radiographic and histopathological findings supported dystrophic calcinosis cutis. Deep-tissue culture grew Escherichia coli, treated with intravenous ertapenem. Tangential excision of necrotic tissue and accessible calcific deposits resulted in an irregular full-thickness defect extending to the pretibial fascia. A synthetic polylactic acid matrix was applied with single-use negative pressure wound therapy for 14 days, followed by split-thickness skin grafting on day 21. Graft take exceeded 90%, and residual areas epithelialized without regrafting. At 12 months, the wound remained completely epithelialized without recurrent ulceration, with pain resolution and return to baseline activities. Conclusions: In this patient with ulcerated dystrophic calcinosis cutis associated with rheumatoid arthritis, staged reconstruction using surgical excision, a polylactic acid matrix, single-use negative pressure wound therapy, and split-thickness skin grafting facilitated recipient-bed preparation and definitive cutaneous closure of the post-excisional defect. This case supports the feasibility of this sequence for wound reconstruction in selected complex ulcerated lesions. Further studies are needed to define its comparative role.
Background/ Objectives: Burn care remains a major clinical challenge, as they require effective wound management to promote healing, reduce pain, and prevent complications. This study aimed to describe the use of a polylactic acid membrane in patients with burns of different depths and to assess wound healing outcomes. Methods: A descriptive case series was conducted including six patients with burn injuries treated with a polylactic acid (PLA) membrane (Suprathel®) at a specialized burn unit. The study was performed according to CARE guidelines. Clinical assessment included burn depth evaluation, pain measurement using the Visual Analog Scale, and scar assessment using the Vancouver Scar Scale. The application of the PLA membrane and its clinical performance during the healing process was described. Results: Complete wound closure was achieved in all cases by re-epithelialization as the PLA adhered, integrated and became transparent, clearly visualizing the progression of healing. Time to re-epithelialization ranged from 14 to 35 days, and final Vancouver Scar Scale scores ranged from 1 to 3 points. No major wound-related complications or local infections were documented during the clinical follow-up period. Conclusions: The use of a PLA membrane in burn management represents a promising advance in wound care, as it was associated with wound closure and pain reduction in this case series, with potential benefits for the optimization of nursing clinical practice.